decitabine nanomicelles (NP2)
Delivery StrategyNP2 denotes decitabine nanomicelles incorporated into a tumor-specific, light-controlled nanotheranostic platform. In the reported 2023 Advanced Materials study, NP2 is used together with oxidation-sensitive nanoparticles loaded with TBE to combine epigenetic therapy with photodynamic therapy for tumor photoimmunotherapy.